Developing and validating risk prediction models in an individual participant data meta-analysis

被引:66
作者
Ahmed, Ikhlaaq [1 ]
Debray, Thomas P. A. [2 ]
Moons, Karel G. M. [2 ]
Riley, Richard D. [1 ]
机构
[1] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England
[2] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
基金
英国医学研究理事会;
关键词
Meta-analysis; Prognostic factor; Prognosis; Individual participant (patient) data; Review; Reporting; PATIENT DATA; EXTERNAL VALIDATION; PROGNOSTIC MODELS; CANCER; IMPACT;
D O I
10.1186/1471-2288-14-3
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
100404 [儿少卫生与妇幼保健学];
摘要
Background: Risk prediction models estimate the risk of developing future outcomes for individuals based on one or more underlying characteristics (predictors). We review how researchers develop and validate risk prediction models within an individual participant data (IPD) meta-analysis, in order to assess the feasibility and conduct of the approach. Methods: A qualitative review of the aims, methodology, and reporting in 15 articles that developed a risk prediction model using IPD from multiple studies. Results: The IPD approach offers many opportunities but methodological challenges exist, including: unavailability of requested IPD, missing patient data and predictors, and between-study heterogeneity in methods of measurement, outcome definitions and predictor effects. Most articles develop their model using IPD from all available studies and perform only an internal validation (on the same set of data). Ten of the 15 articles did not allow for any study differences in baseline risk (intercepts), potentially limiting their model's applicability and performance in some populations. Only two articles used external validation (on different data), including a novel method which develops the model on all but one of the IPD studies, tests performance in the excluded study, and repeats by rotating the omitted study. Conclusions: An IPD meta-analysis offers unique opportunities for risk prediction research. Researchers can make more of this by allowing separate model intercept terms for each study (population) to improve generalisability, and by using 'internal-external cross-validation' to simultaneously develop and validate their model. Methodological challenges can be reduced by prospectively planned collaborations that share IPD for risk prediction.
引用
收藏
页数:15
相关论文
共 43 条
[1]
Individual participant data meta-analyses should not ignore clustering [J].
Abo-Zaid, Ghada ;
Guo, Boliang ;
Deeks, Jonathan J. ;
Debray, Thomas P. A. ;
Steyerberg, Ewout W. ;
Moons, Karel G. M. ;
Riley, Richard David .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2013, 66 (08) :865-873
[2]
Individual participant data meta-analysis of prognostic factor studies: state of the art? [J].
Abo-Zaid, Ghada ;
Sauerbrei, Willi ;
Riley, Richard D. .
BMC MEDICAL RESEARCH METHODOLOGY, 2012, 12
[3]
Assessment of publication bias, selection bias, and unavailable data in meta-analyses using individual participant data: a database survey [J].
Ahmed, Ikhlaaq ;
Sutton, Alexander J. ;
Riley, Richard D. .
BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
[4]
Prognosis and prognostic research: validating a prognostic model [J].
Altman, Douglas G. ;
Vergouwe, Yvonne ;
Royston, Patrick ;
Moons, Karel G. M. .
BMJ-BRITISH MEDICAL JOURNAL, 2009, 338 :1432-1435
[5]
[Anonymous], 2011, Flexible parametric survival analysis using Stata: Beyond the Cox model
[6]
Blak Betina T, 2011, Inform Prim Care, V19, P251
[7]
External validation is necessary in, prediction research: A clinical example [J].
Bleeker, SE ;
Moll, HA ;
Steyerberg, EW ;
Donders, ART ;
Derksen-Lubsen, G ;
Grobbee, DE ;
Moons, KGM .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2003, 56 (09) :826-832
[8]
Reporting and Methods in Clinical Prediction Research: A Systematic Review [J].
Bouwmeester, Walter ;
Zuithoff, Nicolaas P. A. ;
Mallett, Susan ;
Geerlings, Mirjam I. ;
Vergouwe, Yvonne ;
Steyerberg, Ewout W. ;
Altman, Douglas G. ;
Moons, Karel G. M. .
PLOS MEDICINE, 2012, 9 (05)
[9]
Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer-pooled analysis from three multicenter, randomized, controlled trials using individual patient data [J].
Chou, I ;
Norman, AR ;
Cunningham, D ;
Waters, JS ;
Oates, J ;
Ross, PJ .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (12) :2395-2403
[10]
Collins G, 2011, BMJ GROUP BLOGS